Contents
Contents
The DePuy Synthes settlement required the company to pay $9.75 million to resolve allegations that kickbacks in the form of free spinal implants and tools for a surgeon’s overseas operations bought his domestic business. The government alleged that DePuy supplied the products to induce a Massachusetts orthopedic surgeon to choose its devices for surgeries at home. Medicare and Medicaid paid claims for those domestic procedures. A former DePuy sales representative brought the qui tam case.
The Department of Justice announced the settlement on January 20, 2023. DePuy Synthes, Inc. manufactured medical devices and supplies. DePuy Synthes Sales, Inc. distributed, marketed and sold products. Both were wholly owned by Johnson & Johnson.
The free products went to overseas surgeries for patients who were not Medicare or Medicaid beneficiaries. The government’s kickback allegation concerned the surgeon’s use of DePuy products in Massachusetts procedures paid for by those programs. The benefit and the government-funded business were on different sides of the world.
Implant purchasing gives that arrangement its commercial logic. The surgeon can choose or strongly influence the brand and type of implant, while the hospital buys it and receives payment for the procedure. The Department of Health and Human Services’ Office of Inspector General calls implantable devices physician preference items. A manufacturer seeking those sales has a reason to cultivate the person making the choice, even when someone else pays the bill.
The alleged benefit here was practical. The surgeon needed products for operations overseas, where the hospitals or local distributors sometimes did not have them. DePuy’s representatives supplied the implants and instruments in the United States, and the surgeon typically traveled with them. The company helped put the equipment in his hands before he left.
DePuy admitted in its signed settlement agreement that its sales representatives supplied the surgeon with implants and instruments from at least July 2013 through February 2018. The products included cages, rods, screws, plates, and a modular access and retraction system.
The company acknowledged that the surgeon performed more than 20 surgeries over multiple trips to six countries: Bahrain, Saudi Arabia, Kuwait, Lebanon, the United Arab Emirates and Qatar. He used the supplied DePuy products in many of those operations. Neither the surgeon, the overseas hospitals, the distributors nor anyone else paid DePuy for the products used.
DePuy also admitted that it did not track the products it gave him for overseas surgery and did not request payment. That gap matters in a business built around getting the right implant and instrument to the right operating room. Product left through the sales force, went overseas with a surgeon, and was used without a bill from the manufacturer. Taxpayers paid for the domestic procedures that the government said those free products helped secure.
The agreement also records the domestic side. During the same period, and continuing for at least a year, the surgeon used DePuy products in spinal surgeries in Boston, including procedures for which Medicare and Medicaid paid claims. The government’s allegation was that the free products induced or rewarded that domestic use.
The surgeon agreed to pay $200,000 in a separate settlement announced on May 31, 2024. The Justice Department said he admitted the facts behind its allegations concerning the free products and domestic implant use.
The government alleged that he solicited and received more than $100,000 worth of free DePuy products.
A sales employee may know who approved or assembled the supplies. Someone working with the surgeon may know what he requested and where he used it. The overseas operations and the domestic government-paid procedures give those accounts their connection.
The whistleblower’s amended complaint described how employees stocked the travel bags and how sales representatives reported products used in domestic surgeries.
The complaint alleged that representatives received a product inventory and filled surgical bags to the surgeon’s specifications. It described the recurring supply of equipment this way:
Prior to each trip, and about once a quarter, Defendants stock and furnish Dr. #1 with surgical bags filled with surgical tools, supplies, and implants. The total value of each fully stocked set of bags is about anywhere from $250,000 to $500,000.
Whistleblower’s allegation, United States of America and Commonwealth of Massachusetts ex rel. John Doe v. Johnson & Johnson, DePuy Synthes, Inc., and DePuy Synthes Sales, Inc., amended complaint, paragraph 63
The attached inventory makes the work concrete: clamps, inserters, rod holders, screws, cervical plates and bags of cages. Employees allegedly worked from an extensive list, with enough supplies for multiple spinal surgeries.
The people packing those bags could describe the request, the product and the handoff. Their knowledge matters especially beside DePuy’s admission that it did not track the products it gave the surgeon. An employee’s account and a packing inventory can show a transaction that the company’s ordinary sales records miss.
For domestic cases, the complaint described representatives stationed at hospitals with spinal implants and tools. Surgeons sometimes decided the precise implant size during the operation. Afterward, the representative reported what had been used, giving a handwritten report to a nurse and an electronic copy to the hospital business coordinator.
According to the complaint, those reports drove billing and generally a one-for-one restock. That made the replacement inventory a way to compare the reported product with the product actually used. In a broader billing allegation in the same complaint, the whistleblower described the mismatch he saw:
This was evident because monthly sales ledgers purported to show sales of items that Relator knew had not been used; and the depleted inventory would be augmented with the most expensive devices whereas less expensive devices had been expended.
Whistleblower’s allegation, United States of America and Commonwealth of Massachusetts ex rel. John Doe v. Johnson & Johnson, DePuy Synthes, Inc., and DePuy Synthes Sales, Inc., amended complaint, paragraph 46
The complaint alleged that expensive items accumulated while commonly used cheaper items ran short. It also alleged that information from representatives’ reports went directly into hospital billing software. An inventory discrepancy could therefore point back to a report about a particular procedure.
Medicare generally includes an implanted device in its payment for the hospital procedure or stay.
This is why the DePuy allegation reaches through the surgeon to the institution’s claim. The company supplied a benefit to the decision-maker. The government alleged that the resulting device choices caused false claims for domestic health care. The settlement agreement specifically identifies paid Medicare and Medicaid claims for the surgeon’s Boston procedures.
For someone reviewing device sales, the useful connection runs from the product used to the procedure and then to the hospital’s claim. A manufacturer’s invoice, a restock order and a government payment describe different transactions. We work with insiders to connect them.
The DePuy case concerned free implants and instruments. Other device cases have involved consulting fees, royalties and payments for intellectual property tied to surgeons’ product use. What connects those arrangements is the alleged influence on the choice that generates paid healthcare business.
The 2020 Journal of Forensic and Investigative Accounting review, A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud, examines kickbacks as an exchange for purchasing or recommending federally paid care, whether the benefit arrives directly, indirectly, in cash or as goods. The DePuy allegation follows that exchange across borders: equipment went abroad, while the business it allegedly bought stayed at home.
In its civil settlement, Life Spine admitted that management reports compared payments to surgeons with their use of the company’s products. One report calculated the return on those payments using the sales associated with each surgeon. When usage fell, senior sales managers contacted surgeons or distributors to urge more use.
Life Spine’s reports put the benefit and the sales beside each other. In DePuy’s case, the government’s account connected free overseas equipment with domestic implant use. For an insider, the valuable knowledge is how the company understood that relationship and acted on it.
In a free-product case, useful evidence connects what the manufacturer supplied, who chose the device and which domestic procedures generated claims. We work with you to establish those connections. The DePuy complaint gives concrete examples: travel-bag inventories, employees who packed them, product-use reports and restocking records.
The Association of periOperative Registered Nurses’ position on industry representatives calls for documenting the representative’s name, company and time in the room in the intraoperative nursing record under the hospital’s policy.
A sales representative may recognize the product list. An inventory employee may remember the repeated requests. Hospital staff may understand how the product-use report became a billing entry. We build the account with the insider who understands the work, then connect that knowledge to the purchasing decisions and claims.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
The Justice Department’s national announcement reported an award of approximately $1.37 million for the former DePuy sales representative, representing the federal share. Its Massachusetts office reported approximately $1.85 million, including the federal and state shares.
If you know who requested the free equipment, who supplied it or what business followed, speak to one of our Whistleblower Experts. We build your strongest medical device whistleblower case around that inside knowledge and bring in medical device fraud whistleblower lawyers who understand surgeon incentives and hospital claims. We stay beside you as the product trail becomes a case for recovering public money.